| 000 | 01326nam a2200397 i 4500 | ||
|---|---|---|---|
| 999 |
_c12837 _d12837 |
||
| 001 | 23973699 | ||
| 005 | 20210304140110.0 | ||
| 008 | 910531s1991 nyu b 001 0 eng c | ||
| 010 | _a91020144 | ||
| 020 | _a0824784847 (alk. paper) | ||
| 040 |
_aDNLM/DLC _cDLC _dEG-NcFUE _beng _erda |
||
| 050 | 0 | 0 |
_aRM301.45 _b.P454 1991 |
| 060 | 1 | _aQV 38 P531 1991 | |
| 082 | 0 | 0 |
_220 _a615.58 _bP |
| 245 | 0 | 0 |
_aPharmaceutical bioequivalence / _cedited by Peter G. Welling, Francis L.S. Tse, Shrikant V. Dighe |
| 264 | 1 |
_aNew York : _bDekker, _c[1991] |
|
| 264 | 4 | _c©1991 | |
| 300 |
_a467 pages : _billustrations ; _c24 cm. |
||
| 336 |
_2rdacontent _atext _btxt |
||
| 337 |
_2rdamedia _aunmediated _bn |
||
| 338 |
_2rdacarrier _avolume _bnc |
||
| 490 | 0 |
_aDrugs and the pharmaceutical sciences, _vv. 48 |
|
| 504 | _aIncludes bibliographical references and index | ||
| 650 | 0 |
_aDrugs _xTherapeutic equivalency |
|
| 650 | 0 |
_aDrugs _xBioavailability |
|
| 650 | 2 | _aBiological Availability | |
| 650 | 2 | _aDrug Evaluation | |
| 650 | 2 |
_aPharmaceutical Preparations _xadministration & dosage |
|
| 650 | 2 | _aTherapeutic Equivalency | |
| 700 | 1 | 0 | _aWelling, Peter G |
| 700 | 1 | 0 | _aTse, Francis L. S |
| 700 | 1 | 0 | _aDighe, Shrikant V |
| 830 | 0 |
_aDrugs and the pharmaceutical sciences, _vv. 48 |
|
| 942 |
_2ddc _cBK |
||